Fact CheckerSign in

NCT05710653Completed

Inter-individual Physiological Response to a Training and Detraining Period in Cardiometabolic Risk Factors Subjects

Physiological Response to a Training and Detraining Period in Vascular Parameters of Cardiometabolic Risk Factors Subjects: Optimizing Post-exercise Strategies to Maintain Health Benefits in Chilean Adults

Source: ClinicalTrials.gov · Last updated 29 May 2024

Brief summary (registry, in English)

Background: Although exercise training is a well described therapy for some cardiometabolic diseases such as obesity, type 2 diabetes, arterial hypertension, and metabolic syndrome, there is scarcity of knowledge about the post-exercise period term as 'detraining' where usually all physiological adaptations as cardiovascular and metabolic benefits are lost due to physical inactivity. Likewise, as some exercise training modalities as high-intensity interval training improve vascular parameters including endothelial dysfunction parameters as flow-mediated dilation (FMD%), and carotid-intima media thickness (c-IMT) during the 'training' period, there is little knowledge about how many 'volume' or 'intensity' of exercise training or physical activity per week is needed to maintain the exercise training benefits in populations with cardiometabolic risk factors such as those patients with arterial hypertension. This information will be of great interest for both improving and maintaining the vascular profile and health of Chilean adults with risk factors and to maintain a better vascular profile. Objective: To study the beneficial adaptations from the 'training' and 'detraining' period of exercise training on functional and structural vascular parameters in healthy and cardiometabolic risk factors adult subjects to improve the health profile. Methods: The investigators will conduct an experimental design of 5 groups of exercise training in healthy (controls) and hypertensive (HTN) patients (≥140 mmHg), with overweight/or obesity, men and women, with BMI ≥25 and ≤35 kg/m2, aged ≥18y, physically inactive (\<150 min/week of low/moderate PA/week, or \<75 min/week of vigorous PA) in the last 6 months will be invited for participating. The groups will be as follows; Group (HTNex will be compared with Group HTNcg). Group (ELEex will be compared with Group ELEcg). Group (NTex will be compared with Group NTcg). Each group will be compared in their physiological vascular adaptations before and after exercise training such as HIIT, and after 3 months of a detraining period. Results (hypothesis): The investigators hypothesized that the maintenance of vascular outcomes after the 'detraining' period is intensity-dependent in adults with HTN that participated of an exercise intervention.

Status (registry)
Completed
Study type
Interventional
Enrollment
75 (actual)
First submitted
20 Jan 2023
Start date
28 Jun 2022
Primary completion date
24 May 2024
Lead sponsor
Cristian Alvarez
NCT number
NCT05710653

What you commit to

  • Study type: Interventional
  • Participants enrolled: 75
  • From 28 Jun 2022 to the primary completion date, 24 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Type 1 diabetes mellitus
  • Cardiovascular disease (i.e., coronary artery disease)
  • T2DM complications such as varicose ulcer in the foot, legs, or any history of the wound, nephropathies, muscle-skeletal disorders (i.e., osteoarthrosis) that could limit exercise participation, and adaptations, where ExT can be not recommended.

Other

  • Altered ECG
  • Uncontrolled HTN (≥160 mmHg SBP, or DBP \>95 mmHg)
  • Morbid obesity (≥35-40 kg/m2)
  • Subjects under pharmacotherapy that can influence body composition such as weight- loss treatment, as well as those who are enrolled in ExT programs recently (last 3 months)

Who the study is looking for

  • Healthy, or subjects with elevated blood pressure (ELE) or arterial hypertension (HTN)
  • ELE and/or HTN controlled or not controlled with pharmacotherapy
  • With hyperglycemia, type 2 diabetes mellitus (T2DM) controlled or not controlled with pharmacotherapy
  • Living in urban areas of the Concepción or Talcahuano cities
  • Demonstrable ability to adhere to the exercise training programs
  • To sign the written informed consent for participating in the study

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universidad Andres Bello
Coordinator of this site? Confirm its status
TalcahuanoChileUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.